5 Fastest Growing Biotech Companies in the US

3. BioNTech SE (NASDAQ: BNTX)

Headquarters: Mainz, Germany

No. of employees:  1,800

Revenue (2018): $127.5 million

Revenue (2019): $108.6 million

Founded in 2008, BioNTech SE is a biotechnology company that engages in the discovery and development of patient-specific immunotherapies for the treatment of cancer, allergies, infectious diseases, and autoimmune disorders. It operates through two primary business units: Biotech Business and External Services.

Its extensive portfolio of candidate drugs includes individualized and off-the-shelf mRNA-based therapies, bi-specific antibodies, innovative chimeric antigen receptor T cells, targeted cancer antibodies, and small molecules immunomodulators. BioNTech has established a partnership with some leading pharmaceutical giants, including Pfizer, Eli Lilly, Roche, Genmab and Sanofi.

The U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for the BioNTech and Pfizer’s mRNA-based vaccine candidate ‘BNT162b2’ on December 11, 2020. In the phase 3 clinical trial the vaccine demonstrated 95% efficacy rate.